Rialto Wealth Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2054966
SYRACUSE, NY
Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,696
+$1,511 QoQ
Shares Held
16
+77.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#722
of 768 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rialto Wealth Management, LLC holds $40,087 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,174 | $9,152 | |
| 2 | VTRS |
Viatris Inc
|
537 | $8,527 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9 | $4,876 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
164 | $4,036 | |
| 5 | CRON |
Cronos Group Inc.
|
1,000 | $2,780 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
16 | $2,696 | |
| 7 | ZTS |
Zoetis Inc.
|
33 | $2,371 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
133 | $2,302 |
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,696 | 16 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,185 | 9 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $850 | 6 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $701 | 5 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $377 | 3 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||